Kevin Bruce

Kevin joined the team in 2019 as the Chief Operating Officer. He has more than 20 years of working within a regulated scientific environment for a small biotech, large CROs, and SMEs.

With a background in quality control and engineering, Kevin has held positions in Operations, Quality, R&D, and commercial development. He was previously responsible for Roslin Cells’ collaborative projects for the development, GMP translation, and manufacture of cell therapies for both pre-clinical and clinical development. More recently, as COO at Censo Biotechnologies, he established the operational capability for the European Bank for Induced Pluripotent Stem Cells and was responsible for Censo’s stem cell generation, genome editing, and assay development operations for drug discovery.